WELL Health Technologies Corp.

DB:W7V Stock Report

Market Cap: €729.4m

WELL Health Technologies Future Growth

Future criteria checks 1/6

WELL Health Technologies's earnings are forecast to decline at 73.9% per annum while its annual revenue is expected to grow at 9.2% per year. EPS is expected to decline by 29.1% per annum.

Key information

-73.9%

Earnings growth rate

-29.1%

EPS growth rate

Healthcare earnings growth23.1%
Revenue growth rate9.2%
Future return on equityn/a
Analyst coverage

Good

Last updated01 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:W7V - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,173-51021355
12/31/20251,07957711214
12/31/20249831236312315
6/30/20249101476789N/A
3/31/2024838304968N/A
12/31/202377604166N/A
9/30/2023701-76081N/A
6/30/2023643-46176N/A
3/31/2023612-56781N/A
12/31/202256917077N/A
9/30/2022528-292056N/A
6/30/2022482-37549N/A
3/31/2022403-45-1934N/A
12/31/2021302-44-3022N/A
9/30/2021204-29-1310N/A
6/30/2021117-21-102N/A
3/31/202166-9-4-4N/A
12/31/202050-4-7-5N/A
9/30/202043-9-5-4N/A
6/30/202039-10-4-3N/A
3/31/202036-8-4-3N/A
12/31/201933-8-3-3N/A
12/31/20189-2-1-1N/A
10/31/20186-2-1-1N/A
7/31/20184-6-1-1N/A
4/30/20182-6N/A-1N/A
1/31/20180-6N/A-1N/A
10/31/2017N/A-1N/A-1N/A
7/31/20170-1N/A-1N/A
3/31/201700N/A-1N/A
12/31/201600N/A0N/A
10/31/20160-1N/A0N/A
12/31/20150-1N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: W7V's earnings are forecast to decline over the next 3 years (-73.9% per year).

Earnings vs Market: W7V's earnings are forecast to decline over the next 3 years (-73.9% per year).

High Growth Earnings: W7V's earnings are forecast to decline over the next 3 years.

Revenue vs Market: W7V's revenue (9.2% per year) is forecast to grow faster than the German market (5.5% per year).

High Growth Revenue: W7V's revenue (9.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if W7V's Return on Equity is forecast to be high in 3 years time


Discover growth companies